
Effects of OROS-MPH Versus Dl-Amphetamine-XR on Driving Performance of ADHD Adolescents
Abstract
Driving performance of 35 adolescent ADHD patients (19 boys/16 girls; mean age 17.8 years) on a driving simulator was compared while taking OROS methylphenidate (Concerta, 72 mg), mixed dl-amphetamine salts (Adderall XR, 30 mg), or placebo in a randomized, double-blind, crossover study at University of Virginia, Charlottesville.
DOI: https://doi.org/10.15844/pedneurbriefs-20-10-4 | Journal eISSN: 2166-6482
Language: English
Page range: 75 - 76
Published on: Oct 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.